BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6259)

  • 1. Diminution of prostate by ergoline derivative VUFB--6638 (Dironyl) in rats.
    Ausková M; Rezábek K; Marhan O; Zikán V; Semonský M
    Endocrinol Exp; 1979 Sep; 13(3):171-6. PubMed ID: 315868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
    Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
    Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats.
    Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
    Experientia; 1973 Oct; 29(10):1262-3. PubMed ID: 4796640
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].
    Ausková M; Rezábek K; Zikán V; Semonský M
    Experientia; 1974 Apr; 30(4):393-4. PubMed ID: 4858213
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
    Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
    Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of a series of prolactin inhibitors, 17beta-estradiol and 2alpha-methyldihydrotestosterone propionate, on growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas.
    Teller MN; Stock CC; Hellman L; Mountain IM; Bowie M; Rosenberg BJ; Boyar RM; Budinger JM
    Cancer Res; 1977 Nov; 37(11):3932-8. PubMed ID: 409489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent findings on prolactin transformation by the lactating rat pituitary.
    Mena F; Montiel JL; Aguayo D; Morales MT; Arámburo C
    Endocr Regul; 1993 Sep; 27(3):105-13. PubMed ID: 8193309
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of ergot alkaloids on pituitary prolactin and prolactin-dependent processes.
    Floss HG; Cassady JM; Robbers JE
    J Pharm Sci; 1973 May; 62(5):699-715. PubMed ID: 4574586
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal and abnormal prolactin metabolism.
    Chang RJ
    Clin Obstet Gynecol; 1978 Mar; 21(1):125-37. PubMed ID: 24508
    [No Abstract]   [Full Text] [Related]  

  • 11. Ergolines as potential prolactin and mammary tumor inhibitors.
    Cassady JM; Floss HG
    Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.